S&T Bank’s Quest Diagnostics DGX Stock Holding History

S&T Bank’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,000	Closed	-$257K	–	134
2021 Q1	$257K	Hold	2,000	–	–	0.04%	123
2020 Q4	$238K	Buy	+2,000	New	+$244K	0.04%	121

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

S&T Bank's DGX Position: Q2 2021 in Review

S&T Bank sold out of Quest Diagnostics (DGX) in Q2 2021, closing a stake of 2,000 shares — an estimated $257K sold.

S&T Bank first reported a position in DGX in Q4 2020 and held it in 2 quarters. The position peaked at $257K in Q1 2021. 814 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

S&T Bank reported no remaining Quest Diagnostics position as of Q2 2021 after selling out during the quarter.
S&T Bank sold 2,000 Quest Diagnostics shares in Q2 2021, an estimated $257K.
S&T Bank first reported a position in Quest Diagnostics in Q4 2020 and held it in 2 quarters.
S&T Bank's Quest Diagnostics position peaked at $257K in Q1 2021.
814 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on S&T Bank's 13F filing for Q2 2021, filed 13 Aug 2021.